Literature DB >> 29558667

Neurodegenerative disease and cognitive retest learning.

Robert S Wilson1, Ana W Capuano2, Lei Yu2, Jingyun Yang2, Namhee Kim2, Sue E Leurgans2, Melissa Lamar3, Julie A Schneider4, David A Bennett2, Patricia A Boyle3.   

Abstract

Retest learning impacts estimates of cognitive aging, but its bases are uncertain. Here, we test the hypothesis that dementia-related neurodegeneration impairs retest learning. Older persons without cognitive impairment at enrollment (n = 567) had annual cognitive testing for a mean of 11 years, died, and had a neuropathologic examination to quantify 5 neurodegenerative pathologies. Change point models were used to divide cognitive trajectories into an early retest sensitive component and a later component less sensitive to retest. Performance on a global cognitive measure (baseline mean = 0.227, standard deviation = 0.382) increased an estimated mean of 0.142-unit per year for a mean of 1.5 years and declined an estimated mean of 0.123-unit per year thereafter. No pathologic marker was related to cognitive change before the change point; each was related to cognitive decline after the change point. Results were comparable in analyses that used specific cognitive outcomes, included 220 individuals with mild cognitive impairment at enrollment, or allowed a longer retest learning period. The findings suggest that neurodegeneration does not impact cognitive retest learning.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Clinical-pathologic study; Cognitive decline; Longitudinal study; Retest learning; TDP-43 pathology

Mesh:

Substances:

Year:  2018        PMID: 29558667      PMCID: PMC6383720          DOI: 10.1016/j.neurobiolaging.2018.02.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  4 in total

1.  Metamemory and financial decision making in older adults without dementia.

Authors:  Lei Yu; Gary Mottola; Robert S Wilson; Olivia Valdes; David A Bennett; Patricia A Boyle
Journal:  Neuropsychology       Date:  2021-10-28       Impact factor: 3.295

2.  Probucol, a "non-statin" cholesterol-lowering drug, ameliorates D-galactose induced cognitive deficits by alleviating oxidative stress via Keap1/Nrf2 signaling pathway in mice.

Authors:  Jin-Lan Huang; Chao Yu; Min Su; Si-Man Yang; Fan Zhang; Yuan-Yuan Chen; Jin-Yuan Liu; Yi-Fan Jiang; Zhen-Guo Zhong; Deng-Pan Wu
Journal:  Aging (Albany NY)       Date:  2019-10-07       Impact factor: 5.682

3.  Lower practice effects as a marker of cognitive performance and dementia risk: A literature review.

Authors:  Roos J Jutten; Evan Grandoit; Nancy S Foldi; Sietske A M Sikkes; Richard N Jones; Seo-Eun Choi; Melissa L Lamar; Diana K N Louden; Joanne Rich; Douglas Tommet; Paul K Crane; Laura A Rabin
Journal:  Alzheimers Dement (Amst)       Date:  2020-07-09

4.  Cognitive decline and mortality in a community-based sample of homeless and precariously housed adults: 9-year prospective study.

Authors:  Kristina M Gicas; Andrea A Jones; Allen E Thornton; Anna Petersson; Emily Livingston; Kristina Waclawik; William J Panenka; Alasdair M Barr; Donna J Lang; Fidel Vila-Rodriguez; Olga Leonova; Ric M Procyshyn; Tari Buchanan; G William MacEwan; William G Honer
Journal:  BJPsych Open       Date:  2020-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.